[go: up one dir, main page]

HN2009003038A - Anticuerpos contra la il-25 - Google Patents

Anticuerpos contra la il-25

Info

Publication number
HN2009003038A
HN2009003038A HN2009003038A HN2009003038A HN2009003038A HN 2009003038 A HN2009003038 A HN 2009003038A HN 2009003038 A HN2009003038 A HN 2009003038A HN 2009003038 A HN2009003038 A HN 2009003038A HN 2009003038 A HN2009003038 A HN 2009003038A
Authority
HN
Honduras
Prior art keywords
antibodies against
interleuquina
ancere
diana
asthma
Prior art date
Application number
HN2009003038A
Other languages
English (en)
Inventor
Neil James Mckenzie Andrew
Ballantyne Sarah
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of HN2009003038A publication Critical patent/HN2009003038A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION PROPORCIONA EL ANTCUERPO 2C3 Y MIEMBROS DE UNION A DIANA BASADOS EN 2C3 QUE SE UNEN A LA INTERLEUQUINA-25. ESTOS SON UTILES EN TERAPIA, POR EJEMPLO, EN EL TRATAMIENTO DEL ASMA.
HN2009003038A 2007-04-18 2009-10-16 Anticuerpos contra la il-25 HN2009003038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91247407P 2007-04-18 2007-04-18
GBGB0707505.4A GB0707505D0 (en) 2007-04-18 2007-04-18 Antibodies against il-25

Publications (1)

Publication Number Publication Date
HN2009003038A true HN2009003038A (es) 2011-11-11

Family

ID=38135020

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2009003038A HN2009003038A (es) 2007-04-18 2009-10-16 Anticuerpos contra la il-25

Country Status (32)

Country Link
US (1) US8206717B2 (es)
EP (1) EP2144934B1 (es)
JP (1) JP5366930B2 (es)
KR (1) KR101605861B1 (es)
CN (1) CN101711256B (es)
AU (1) AU2008240436B2 (es)
BR (1) BRPI0810418A8 (es)
CA (1) CA2684492C (es)
CO (1) CO6260104A2 (es)
CR (1) CR11079A (es)
CY (1) CY1118244T1 (es)
DK (1) DK2144934T3 (es)
EA (1) EA018073B1 (es)
EC (1) ECSP099726A (es)
ES (1) ES2604255T3 (es)
GB (1) GB0707505D0 (es)
GT (1) GT200900271A (es)
HN (1) HN2009003038A (es)
HR (1) HRP20161548T1 (es)
HU (1) HUE030935T2 (es)
IL (1) IL201552A (es)
LT (1) LT2144934T (es)
MX (1) MX2009011234A (es)
MY (1) MY148451A (es)
NI (1) NI200900189A (es)
NZ (1) NZ581178A (es)
PL (1) PL2144934T3 (es)
PT (1) PT2144934T (es)
RS (1) RS55401B1 (es)
SI (1) SI2144934T1 (es)
UA (1) UA100377C2 (es)
WO (1) WO2008129263A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25
US8574582B2 (en) * 2008-10-31 2013-11-05 Janssen Biotech, Inc. Methods for mediating fibrotic response
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
JP5913103B2 (ja) 2009-09-14 2016-04-27 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ 酵母ベースの免疫療法組成物を含む組合せ物及び被験者のスクリーニング方法
SG184195A1 (en) 2010-03-30 2012-11-29 Janssen Biotech Inc Humanized il-25 antibodies
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法
JP6694877B2 (ja) * 2014-09-23 2020-05-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 抗ｉｌ−２５抗体およびその使用
CA3018058A1 (en) * 2016-03-16 2017-09-21 Richard A. Shimkets Neutralizing monoclonal antibodies to il-25 and uses thereof
WO2018017864A2 (en) * 2016-07-20 2018-01-25 Oncomed Pharmaceuticals, Inc. Pvrig-binding agents and uses thereof
US11285191B2 (en) 2016-07-26 2022-03-29 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Immunostimulatory compositions and uses therefor
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES USING CHIMERIC PROTEIN
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
EP3883965A4 (en) 2018-11-19 2022-10-12 Suzhou Kanova Biopharmaceutical Co., Ltd. ANTI-IL-25 ANTIBODIES AND THEIR USE
GB202018015D0 (en) 2020-11-16 2020-12-30 Res & Innovation Uk Composition and methods for the treatment of intestinal cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
CN1289668C (zh) * 2003-06-12 2006-12-13 北京安波特基因工程技术有限公司 一种用于抗体改形的体外分子定向进化方法
WO2006094384A1 (en) 2005-03-08 2006-09-14 Genesense Technologies Inc. Use of interleukin 17e for the treatment of cancer
US20070237763A1 (en) 2005-10-06 2007-10-11 Baylor Research Institute Compositions and methods for the treatment of cancer
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25

Also Published As

Publication number Publication date
KR101605861B1 (ko) 2016-03-24
AU2008240436A1 (en) 2008-10-30
EA018073B1 (ru) 2013-05-30
KR20100021569A (ko) 2010-02-25
SI2144934T1 (sl) 2016-12-30
CN101711256B (zh) 2013-10-16
UA100377C2 (en) 2012-12-25
ES2604255T3 (es) 2017-03-06
MY148451A (en) 2013-04-30
NZ581178A (en) 2012-01-12
CY1118244T1 (el) 2017-06-28
CO6260104A2 (es) 2011-03-22
RS55401B1 (sr) 2017-04-28
PL2144934T3 (pl) 2017-07-31
IL201552A0 (en) 2010-05-31
EP2144934B1 (en) 2016-08-24
HRP20161548T1 (hr) 2016-12-30
CN101711256A (zh) 2010-05-19
PT2144934T (pt) 2016-12-02
GB0707505D0 (en) 2007-05-30
CA2684492A1 (en) 2008-10-30
LT2144934T (lt) 2016-12-27
AU2008240436B2 (en) 2011-03-17
JP5366930B2 (ja) 2013-12-11
EA200901421A1 (ru) 2010-10-29
IL201552A (en) 2015-08-31
WO2008129263A1 (en) 2008-10-30
JP2010524450A (ja) 2010-07-22
US8206717B2 (en) 2012-06-26
HUE030935T2 (en) 2017-06-28
BRPI0810418A2 (pt) 2014-10-14
ECSP099726A (es) 2010-01-29
GT200900271A (es) 2010-11-03
CA2684492C (en) 2015-11-24
BRPI0810418A8 (pt) 2018-12-11
MX2009011234A (es) 2010-02-18
CR11079A (es) 2010-03-03
DK2144934T3 (en) 2016-12-12
US20100129380A1 (en) 2010-05-27
NI200900189A (es) 2010-09-13
EP2144934A1 (en) 2010-01-20

Similar Documents

Publication Publication Date Title
HN2009003038A (es) Anticuerpos contra la il-25
CY1114872T1 (el) Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης
CY1119892T1 (el) Φορεις και αλληλουχιες για την αγωγη ασθενειων
CL2018002291A1 (es) Anticuerpos anti-fgfr2iiib afucosilados (divisional solicitud 201600221)
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
EA201171367A1 (ru) Винилиндазолильные соединения
CR20110496A (es) Biespecificos anticuerpos anti-her
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
HN2007015177A (es) Derivados de triazolopirazina
MX377710B (es) Anticuerpos monoclonales contra bcma.
CO6571886A2 (es) Antagonistas de pcsk9
MX2018010295A (es) Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos.
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
MX2017014199A (es) Composiciones de nanoparticulas para terapia sostenida.
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
MX2022006573A (es) Uso de anticuerpos anti-il-23a para tratar enfermedades inflamatorias.
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
EA201270433A1 (ru) Лечение аутоиммунных и воспалительных заболеваний эпратузумабом
UY32647A (es) Composiciones farmacéuticas sólidas y procesos para producción
BR112015023797A2 (pt) proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
EA201200118A1 (ru) Дифференцировка мезенхемальных стволовых клеток
CY1121167T1 (el) Βελτιωμενα αντισωματα εναντι της ανθρωπινης φρακταλκινης και χρησεις αυτων
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
MX380252B (es) Crenezumab para usarse en el tratamiento de enfermedad de alzheimer.